{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:58:41Z","timestamp":1790024321808,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s40292-021-00476-4","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T12:05:25Z","timestamp":1633089925000},"page":"589-596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Administration of Subcutaneous Furosemide in Elastomeric Pump vs. Oral Solution for the Treatment of Diuretic Refractory Congestion"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9696-2313","authenticated-orcid":false,"given":"Raquel","family":"L\u00f3pez-Vilella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"S\u00e1nchez-L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Husillos Tamarit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Monte Boquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"N\u00fa\u00f1ez Villota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Donoso Trenado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mart\u00ednez Dolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Almenar Bonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"476_CR1","first-page":"1","volume":"2021","author":"TA Mcdonagh","year":"2021","unstructured":"Mcdonagh TA, Metra M, Adamo M, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;2021:1\u2013128.","journal-title":"Eur Heart J"},{"issue":"3","key":"476_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.hfc.2015.03.010","volume":"11","author":"TJ Fendler","year":"2015","unstructured":"Fendler TJ, Swetz KM, Allen LA. Team-based palliative and end-of-life care for heart failure. Heart Fail Clin. 2015;11(3):479\u201398.","journal-title":"Heart Fail Clin"},{"issue":"19","key":"476_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","volume":"35","author":"MA Valente","year":"2014","unstructured":"Valente MA, Voors AA, Damman K, et al. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 2014;35(19):1284\u201393.","journal-title":"Eur Heart J"},{"issue":"6","key":"476_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/clc.20771","volume":"33","author":"JR Chiong","year":"2010","unstructured":"Chiong JR, Cheung RJ. Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue. Clin Cardiol. 2010;33(6):345\u201352.","journal-title":"Clin Cardiol"},{"issue":"3","key":"476_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1191\/0269216304pm1006oa","volume":"19","author":"C Fonzo-Christe","year":"2005","unstructured":"Fonzo-Christe C, Vukasovic C, Wasilewski-Rasca AF, et al. Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review. Palliat Med. 2005;19(3):208\u201319.","journal-title":"Palliat Med"},{"issue":"16","key":"476_CR6","first-page":"240","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):240\u2013327.","journal-title":"Circulation"},{"key":"476_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/eurjhf\/hfp041","volume":"11","author":"T Jaarsma","year":"2009","unstructured":"Jaarsma T, Beattie JM, Ryder M, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009;11:433\u201343.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"476_CR8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/ejhf.1145","volume":"20","author":"J Com\u00edn-Colet","year":"2018","unstructured":"Com\u00edn-Colet J, Manito N, Segovia-Cubero J, et al. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial. Eur J Heart Fail. 2018;20(7):1128\u201336.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"476_CR9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/ejhf.1531","volume":"21","author":"PM Seferovic","year":"2019","unstructured":"Seferovic PM, Ponikowski P, Anker SD, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patients management. An expert consensus meeting report of the Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21(10):1169\u201386.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"476_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","volume":"23","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017;23(8):628\u201351.","journal-title":"J Card Fail"},{"issue":"12","key":"476_CR11","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.recesp.2013.06.010","volume":"66","author":"E Zatarain-Nicol\u00e1s","year":"2013","unstructured":"Zatarain-Nicol\u00e1s E, L\u00f3pez-D\u00edaz J, de la Fuente-Gal\u00e1n L, et al. Tratamiento de la insuficiencia cardiaca descompensada con furosemida subcut\u00e1nea mediante bombas elastom\u00e9ricas: experiencia inicial. Rev Esp Cardiol. 2013;66(12):999\u20131005.","journal-title":"Rev Esp Cardiol"},{"issue":"2","key":"476_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion-a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21(2):137\u201355.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"476_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jchf.2019.10.012","volume":"8","author":"M Griffin","year":"2020","unstructured":"Griffin M, Soufer A, Goljo E, et al. Real world use of hypertonic saline in refractory acute decompensated heart failure: A.U.S. Center\u2019s Experience. JACC Heart Fail. 2020;8(3):199\u2013208.","journal-title":"JACC Heart Fail."},{"issue":"4","key":"476_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11739-019-02083-7","volume":"14","author":"AM Marra","year":"2019","unstructured":"Marra AM, Proietti M. Diuretic resistance in decompensated chronic heart failure: trying to get out of the loop. Intern Emerg Med. 2019;14(4):497\u20138.","journal-title":"Intern Emerg Med"},{"issue":"23","key":"476_CR15","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","volume":"36","author":"K Damman","year":"2015","unstructured":"Damman K, Testani JM. The kidney in heart failure: an update. Eur Heart J. 2015;36(23):1437\u201344.","journal-title":"Eur Heart J"},{"issue":"4","key":"476_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1345\/aph.1D332","volume":"38","author":"AK Verma","year":"2004","unstructured":"Verma AK, da Silva JH, Kuhl DR. Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study. Ann Pharmacother. 2004;38(4):544\u20139.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"476_CR17","first-page":"44","volume":"27","author":"DS del Prado","year":"2020","unstructured":"del Prado DS, Sancho Zamora MA, Collazo S, et al. Perfusi\u00f3n de furosemida subcut\u00e1nea como tratamiento paliativo en insuficiencia card\u00edaca refractaria. Rev Colomb Cardiol. 2020;27(1):44\u20138.","journal-title":"Rev Colomb Cardiol."},{"issue":"2","key":"476_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4321\/S1699-695X2015000200005","volume":"8","author":"G Romero Candela","year":"2015","unstructured":"Romero Candela G, Tejada CF. \u00bfQu\u00e9 inyectables pueden ser administrados por v\u00eda oral o enteral? Rev Cl\u00edn Med Fam. 2015;8(2):119\u201324.","journal-title":"Rev Cl\u00edn Med Fam"},{"issue":"1","key":"476_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/bmjspcare-2011-000199","volume":"2","author":"JM Beattie","year":"2012","unstructured":"Beattie JM, Johnson MJ. Subcutaneous furosemide in advanced heart failure: has clinical practice run ahead of the evidence base? BMJ Support Palliat Care. 2012;2(1):5\u20136.","journal-title":"BMJ Support Palliat Care"},{"key":"476_CR20","doi-asserted-by":"publisher","unstructured":"Kida K, Doi S, Suzuki N (2020) Palliative care in patients with advanced heart failure. Heart Fail Clin 16(2):243-54. https:\/\/doi.org\/10.1016\/j.hfc.2019.12.006","DOI":"10.1016\/j.hfc.2019.12.006"},{"issue":"3","key":"476_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/eci.12234","volume":"44","author":"H Takase","year":"2014","unstructured":"Takase H, Dohi Y. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship. Eur J Clin Invest. 2014;44(3):303\u20138.","journal-title":"Eur J Clin Invest"},{"key":"476_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ejhf.1962","volume":"22","author":"W Mullens","year":"2020","unstructured":"Mullens W, Damman K, Testani JM, et al. Eur J Heart Fail. 2020;22:1\u201320.","journal-title":"Eur J Heart Fail."},{"key":"476_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jacc.2014.12.010","volume":"65","author":"FH Verbrugge","year":"2015","unstructured":"Verbrugge FH, Steels P, Grieten L, et al. Hyponatremia in acute decompensated heart failure: depletion versus dilution. J Am Coll Cardiol. 2015;65:480\u201392.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"476_CR24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.rce.2017.02.013","volume":"217","author":"A Pose","year":"2017","unstructured":"Pose A, Almenar L, Manzano L, et al. Hyponatraemia and congestive heart failure refractory to diuretic treatment. Utility of tolvaptan. Rev Clin Esp. 2017;217(7):398\u2013404.","journal-title":"Rev Clin Esp."},{"issue":"4","key":"476_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.recesp.2012.09.012","volume":"66","author":"YM Rodr\u00edguez-de Mu\u00f1oz","year":"2013","unstructured":"Rodr\u00edguez-de Mu\u00f1oz YM, S\u00e1nchez-L\u00e1zaro IJ, Almenar-Bonet L, et al. Use of tolvaptan in patients with hyponatremia due to heart failure: initial experience. Rev Esp Cardiol. 2013;66(4):319\u201321.","journal-title":"Rev Esp Cardiol"},{"issue":"2","key":"476_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ehf2.12124","volume":"4","author":"A Pose","year":"2017","unstructured":"Pose A, Almenar L, Gavira JJ, et al. Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project. ESC Heart Fail. 2017;4(2):130\u20137.","journal-title":"ESC Heart Fail."},{"issue":"6","key":"476_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/0269216311399490","volume":"25","author":"H Zacharias","year":"2011","unstructured":"Zacharias H, Raw J, Nunn A, et al. Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure? Palliat Med. 2011;25(6):658\u201363.","journal-title":"Palliat Med"},{"issue":"3","key":"476_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.recesp.2013.10.009","volume":"67","author":"MA Sancho-Zamora","year":"2014","unstructured":"Sancho-Zamora MA. Home subcutaneous infusion of furosemide in advanced decompensated heart failure. Rev Esp Cardiol. 2014;67(3):241\u20132.","journal-title":"Rev Esp Cardiol"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-021-00476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-021-00476-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-021-00476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T10:09:29Z","timestamp":1636798169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-021-00476-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1007\/s40292-021-00476-4","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"assertion":[{"value":"13 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}